Notice of Availability of Administrative Supplements for Dissemination of Surveillance Research

Notice Number: NOT-CA-07-004

Key Dates
Release Date: January 9, 2007

Issued by
National Cancer Institute (NCI) (http://www.cancer.gov/)

Purpose

The NCI is hereby announcing an opportunity for eligible applicants to submit requests for administrative supplements for NCI-funded cancer control research R01, P01, P50, U01, and U19 grants.  Applicants may apply for supplemental funding in connection with a related R01, P01, P50, U01, or U19 research award, as long as all of the following conditions are met: 1) the cancer control topic area is related to the focus of the surveillance research supplement that is being proposed (for example, if the parent grant focuses on physical activity, the supplement would disseminate surveillance data of physical activity); 2) there are no funds in the parent award related to the proposed surveillance dissemination effort; 3) there must be an active parent grant during the entire funding period of this supplement; and 4) the Principal Investigator (PI) for the supplement must be the PI of the parent grant.

These supplements have been designed to provide 1-year funding to cancer control investigators who are conducting peer-reviewed research (with an active NCI grant award) of cancer throughout the cancer control continuum, including, but not limited to, risk factors, screening, cancer rates, treatment, and outcomes.  All such supplements must focus on surveillance research.  Areas of surveillance research, across the cancer control continuum, that may be eligible for supplemental funding include, but are not limited to: tobacco use; diet and physical activity patterns; sun exposure and ultraviolet (UV) radiation exposure; use of chemopreventive agents; use of genetic testing for cancer susceptibility; use of screening for breast, cervix, and colorectal cancers; cancer rates, morbidity and mortality; cancer treatment and patterns of care; and cancer outcomes.

Examples of research objectives for the surveillance supplements may include: (1) testing strategies for applying surveillance data to problems in cancer-related policy, programs, and practice across the cancer continuum; (2) communications research to test different ways to “tell compelling stories” with surveillance research data; and (3) improving strategies for the dissemination of surveillance research tools and data, including: (a) the development and evaluation of tools for communication and education to new audiences who may benefit from the knowledge of surveillance research tools and data; (b) the development of new methods for analyzing surveillance data to be directly applicable to developing policy, programs, and practice in specific communities, practice areas, or populations; (c) the development of data use tools or training venues for increasing the use of surveillance tools and data; and (d) developing and/or testing methods for educating communities on the use of surveillance research to improve cancer-related policy, programs, and practice in their communities.

Detailed instructions for applying for this supplement will be posted at http://dccps.cancer.gov/funding_apply.html#dd on January 31, 2007. The receipt date for request-for-administrative-supplement applications at the NCI address given below is May 1, 2007.

The request-for-administrative-supplement application should take the form of a request that contains sufficient detail (similar to a standard research application) to allow assessment of the scientific merit of the proposed surveillance research dissemination plans and the appropriateness of the request for supplemental funding (see web site for more detailed application information).  Budgets should not exceed $100,000 in total costs for a time period not exceeding 12 months.  All requests require an itemized budget and must be countersigned by the grantee institution's business office.  Requests for supplements under this program must comply with NIH policies for inclusion of women, minorities, and children in research involving human subjects.

Requests will be evaluated by NCI program staff (and appropriate consultants) who have expertise in the cancer control surveillance research area and/or in research dissemination.  Awards will be determined on the basis of scientific merit, program relevance, dissemination potential, and availability of funds.  Special consideration will be given to applications that include plans to disseminate surveillance research information concerning low income and ethnically diverse populations.

Inquiries related to this Notice should be addressed to the NCI Program Director for the particular R01, P01, P50, U01, or U19 grant for which the supplement is being requested. Before submitting a request letter, each applicant (i.e., PI) is encouraged to discuss the feasibility of their research dissemination proposal with the Program Director for the NCI research project parent grant.

The earliest anticipated award date for supplements associated this funding opportunity will be September 1, 2007.

Inquiries
Direct inquiries concerning the programmatic and review matters should be directed to:

Jon F. Kerner, Ph.D.
Deputy Director for Research Dissemination and Diffusion
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Boulevard, EPN Room 6144, MSC 0001
Bethesda, MD 20892-0001 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for courier/express delivery)
Telephone: 301-594-7294
E-mail: jon.kerner@nih.gov

Direct inquiries regarding administrative and fiscal matters should be directed to:

Crystal Wolfrey
Office of Grants Administration
National Cancer Institute
6120 Executive Boulevard, EPS Room 243, MSC 7150
Bethesda, MD 20892-7150 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for courier/express delivery)
Telephone: 301-496-8634
E-mail: crystal.wolfrey@nih.gov

Submission of Request

Submit a signed, typewritten original of the request and five signed, single-sided photocopies, in one package to:

Emily Dowling
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Boulevard, EPN Room 4111, MSC 0001
Bethesda, MD 20892-0001 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for express/courier delivery)

Do Not Submit the Applications to the Center for Scientific Review (CSR).


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.